Compare BAH & GKOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BAH | GKOS |
|---|---|---|
| Founded | 1914 | 1998 |
| Country | United States | United States |
| Employees | 31500 | N/A |
| Industry | Professional Services | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.3B | 9.7B |
| IPO Year | 2010 | 2015 |
| Metric | BAH | GKOS |
|---|---|---|
| Price | $88.60 | $239.97 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 15 | 13 |
| Target Price | $89.00 | ★ $234.00 |
| AVG Volume (30 Days) | ★ 1.8M | 1.2M |
| Earning Date | 10-23-2026 | 10-28-2026 |
| Dividend Yield | ★ 2.80% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 3.13 | N/A |
| Revenue | ★ $11,217,000,000.00 | $507,442,000.00 |
| Revenue This Year | $1.37 | $53.82 |
| Revenue Next Year | $4.61 | $28.70 |
| P/E Ratio | $26.83 | ★ N/A |
| Revenue Growth | N/A | ★ 32.33 |
| 52 Week Low | $59.50 | $80.91 |
| 52 Week High | $109.10 | $243.71 |
| Indicator | BAH | GKOS |
|---|---|---|
| Relative Strength Index (RSI) | 79.07 | 85.03 |
| Support Level | $74.35 | $147.72 |
| Resistance Level | $90.54 | N/A |
| Average True Range (ATR) | 3.01 | 8.77 |
| MACD | 1.48 | 7.47 |
| Stochastic Oscillator | 91.54 | 90.15 |
Booz Allen Hamilton Holding Corp provides technology solutions in areas such as artificial intelligence, cybersecurity, and related fields. The company serves U.S. federal government agencies, commercial clients, and select international customers. It also provides technologies to evolve defense missions and delivers solutions to warfighters in the digital battlespace. The domains includes Consulting Services- Delivering strategic, operational, and management consulting to transform organizations; Advanced Tech- artificial intelligence, cloud integration, and data platforms. Cybersecurity that protects critical national infrastructure, military networks, and sensitive government systems and Engineering Solutions providing mission-critical technical design and hardware integration.
Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. The company has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.